Sana Biotechnology Inc (SANA) Stock Analysis

Sana Biotechnology Inc (SANA) is a publicly traded company in the HEALTHCARE sector. It trades at $3.24, carries a market capitalization of $918.36M. This page summarizes the public market data, fundamentals, and frequently asked questions for SANA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Sana Biotechnology Inc currently has a Neutral sentiment score of 0.09.

About Sana Biotechnology Inc

Sana Biotechnology, Inc. is a leading biotechnology company based in Seattle, Washington, dedicated to pioneering engineered cell therapies to address critical unmet medical needs across various disease areas. Utilizing its advanced cell-engineering platform, Sana focuses on innovative treatments in gene therapy and regenerative medicine, aiming to transform existing therapeutic approaches and improve patient outcomes. With a robust pipeline supported by strong research and development initia...

GNG Research Analysis

GNG Research scores Sana Biotechnology Inc (SANA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SANA.

Frequently Asked Questions

Does SANA pay dividends?

Sana Biotechnology Inc (SANA) does not currently pay a regular dividend.

What is SANA's market cap?

Sana Biotechnology Inc (SANA) has a market capitalization of $918.36M with a current stock price of $3.24.